On 7 October 2026, researchers from the Chinese Academy of Sciences reported that ozone, ultraviolet and biological activated carbon stages at a full-scale Tianjin wastewater plant can push anti-androgenic activity above a new safety threshold, even as they suppress estrogen- and thyroid-linked effects (Bioengineer.org).
The peer-reviewed paper, published on 27 July 2026 in Energy & Environment Nexus, used recombinant yeast assays carrying human estrogen, androgen and thyroid receptors to track total biological activity across every stage of the Tianjin plant and two pilot trains (Bioengineer.org).
Key takeaways
- UV irradiation and ozonation raised anti-androgenic activity above the study's newly derived trigger value of 7.97 micrograms of flutamide equivalents per litre (Bioengineer.org).
- Estrogen receptor-antagonistic activity fell from 58.4 micrograms per litre in the influent to roughly 7.8 to 9.2 micrograms per litre after treatment (Bioengineer.org).
- Thyroid receptor-antagonistic activity dropped from 0.56 milligrams per litre to 0.0085 milligrams per litre through the main plant, with a slight rebound after coagulation (Bioengineer.org).
- Androgen receptor-agonistic activity was not detected at any point in the treatment train (Bioengineer.org).
- The team assessed combined chemical-mixture effects with effect-based tools rather than relying on targeted chemical analysis alone (Bioengineer.org).
What happened
Water scarcity is driving cities to expand wastewater reuse, and ozonation, UV irradiation and biological activated carbon (BAC) filtration are widely promoted as the polishing steps that make reclaimed water safe (Bioengineer.org). The Tianjin study, led by Mei Ma's team at the Chinese Academy of Sciences, sampled 11 points along a full-scale treatment train and two pilot systems covering the inlet, preliminary sedimentation, anaerobic-anoxic-oxic (A2O) biological treatment, secondary sedimentation, UV disinfection, ozonation, coagulation and BAC filtration (Bioengineer.org). Organic compounds were concentrated by solid-phase extraction before bioassay (Bioengineer.org).
The results split cleanly across endpoints. Conventional A2O biological treatment stripped most estrogen- and thyroid-linked activity: estrogen receptor-agonistic activity fell below the detection limit after secondary sedimentation, and thyroid receptor-antagonistic activity collapsed by roughly two orders of magnitude through the main plant (Bioengineer.org). In pilot tests, ozonation, and ozonation followed by BAC, drove thyroid receptor-antagonistic activity still lower, though coagulation produced a small rebound the authors link to residual endocrine-disrupting chemicals competing with bulk organics (Bioengineer.org).
The androgen-receptor data went the other way. The A2O stage cut androgen receptor-antagonistic activity from 156.6 to 12.4 micrograms of flutamide equivalents per litre, a roughly twelvefold reduction that should have left the effluent comfortably below the new 7.97 microgram per litre trigger value (Bioengineer.org). UV and ozone then pushed anti-androgenic activity back above that threshold, and BAC downstream of ozone did not fully reverse the rise (Bioengineer.org). The study's authors argue this is consistent with oxidation and photochemistry generating transformation products whose endocrine properties differ from the parent compounds that routine chemical screens are designed to catch (Bioengineer.org).
No direct quote from a named author is present in the supplied reporting; the headline finding is therefore summarised in the study authors' own framing that "the very processes designed to scrub contaminants from effluent can create new biological hazards that conventional monitoring never sees" (Bioengineer.org).
Specification read
The plant under study is described as a typical Chinese municipal wastewater treatment works, with the Tianjin site's daily flow and population equivalent not given in the supplied reporting. For a buyer translating this finding into a specification, the train to benchmark is screening and grit removal, primary clarification, biological treatment using A2O, secondary sedimentation, a tertiary block built around UV, ozone or ozone plus biological activated carbon, coagulation and final disinfection, with effect-based bioassays sitting alongside the usual chemical and toxicity screens. The event bears directly on the polishing block, not on the secondary biological stage that performed as designed. Oxidation and photolysis are core to many reuse schemes we see, and they tie in to municipal reuse trains where reclaimed water is sent to industry, aquifer recharge or indirect potable reuse. Plants targeting effluent for industrial reuse, where buyers compare membrane bioreactor systems and downstream oxidation, should expect a spec reviewer to ask how the polishing stage is being validated against androgen-receptor antagonism, not just bulk organics and AOX. Operators wrestling with the same trade-offs in related sectors can also compare notes through the industries we serve hub.
If your plant looks like a municipal works in the 50 to 500 m³/day to tens-of-thousands m³/day range, with a conventional BOD envelope and a regulatory driver to push more flow to reuse, the Tianjin data say that polishing with UV or ozone can satisfy colour, UV254 and estrogen screens while quietly failing a new endocrine endpoint, and that adding BAC after ozone does not, on its own, fix it.
FAQ
What did the Tianjin study actually find that buyers need to know?
Conventional A2O biology cut androgen-receptor antagonism about twelvefold, from 156.6 to 12.4 micrograms of flutamide equivalents per litre, but downstream UV and ozone pushed the value above the study's 7.97 microgram per litre trigger, and BAC after ozone did not bring it fully back (Bioengineer.org).
Is the problem the chemicals left in the water, or what the polishing stages create?
The authors attribute the rise to transformation products generated by oxidation and photolysis, whose biological activity differs from the parent compounds that targeted chemical analysis is set up to detect (Bioengineer.org).
How does this change a reuse-project specification?
Effect-based monitoring with recombinant yeast assays for estrogen, androgen and thyroid receptors would need to be added to the acceptance criteria, with the study's 7.97 microgram of flutamide equivalents per litre threshold as a working benchmark until site-specific trigger values are set (Bioengineer.org).
Where can operators read more on related polishing trade-offs?
The Bioengineer.org coverage of the Mei Ma team's paper links the finding to broader decisions on advanced treatment trains, and operators weighing MBR-based reuse against conventional activated sludge can compare options in the MBR vs conventional activated sludge guide or the chromium removal methods comparison for context on polishing-stage design choices.
